GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:GSK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Jun 24	BuyUK£32,291	Jonathan Symonds	Individual	2,000	UK£16.15
20 Jun 24	BuyUK£7,196	Wendy Mira Becker	Individual	446	UK£16.14
01 Feb 24	BuyUK£54,972	Jonathan Symonds	Individual	3,500	UK£15.71
01 Feb 24	BuyUK£306,430	Julie Brown	Individual	19,360	UK£15.83
20 Dec 23	BuyUK£28,907	Jonathan Symonds	Individual	2,000	UK£14.45
20 Dec 23	BuyUK£6,929	Urs Rohner	Individual	478	UK£14.50
20 Sep 23	BuyUK£28,994	Jonathan Symonds	Individual	1,900	UK£15.26
20 Sep 23	BuyUK£6,925	Urs Rohner	Individual	453	UK£15.29

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,569,805	0.0385%
Individual Insiders	2,970,921	0.0728%
State or Government	6,659,162	0.163%
Private Companies	47,910,873	1.17%
Employee Share Scheme	73,359,598	1.8%
General Public	461,796,792	11.3%
Institutions	3,483,877,009	85.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.23% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.24%	Dodge & Cox	376,950,772	UK£5.9b	0.05%	2.35%
8.35%	BlackRock, Inc.	340,540,662	UK£5.3b	1.82%	0.11%
4.68%	The Vanguard Group, Inc.	190,753,311	UK£3.0b	0.69%	0.06%
2.22%	State Street Global Advisors, Inc.	90,701,102	UK£1.4b	-5.4%	0.07%
2.11%	Norges Bank Investment Management	86,109,073	UK£1.3b	-4.72%	0.14%
2.11%	FMR LLC	85,962,199	UK£1.3b	58.6%	0.11%
2.06%	Legal & General Investment Management Limited	83,966,630	UK£1.3b	-0.99%	0.32%
1.8%	GlaxoSmithKline Employee Trust	73,359,598	UK£1.1b	-10.9%	no data
1.71%	Wellington Management Group LLP	69,900,134	UK£1.1b	101%	0.21%
1.69%	Schroder Investment Management Limited	69,006,662	UK£1.1b	2.76%	0.9%
1.51%	UBS Asset Management AG	61,509,996	UK£957.7m	-1.65%	0.15%
1.24%	Silchester International Investors LLP	50,407,050	UK£784.8m	-9.18%	3.68%
1.15%	GlaxoSmithKline plc, Shareview Client	46,761,189	UK£728.1m	-2.77%	no data
1.14%	Mondrian Investment Partners Limited	46,540,156	UK£724.6m	-10.9%	5.42%
1.12%	HSBC Global Asset Management (UK) Limited	45,611,017	UK£710.2m	-10.7%	0.41%
1.03%	Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm	41,886,734	UK£652.2m	-1.23%	22.1%
0.99%	Aviva Investors Global Services Ltd.	40,527,854	UK£631.0m	9.63%	1.12%
0.97%	Columbia Management Investment Advisers, LLC	39,628,219	UK£617.0m	-12.5%	0.18%
0.85%	Fisher Asset Management, LLC	34,682,819	UK£540.0m	0.3%	0.31%
0.78%	JP Morgan Asset Management	31,823,875	UK£495.5m	3.67%	0.08%
0.74%	Franklin Resources, Inc.	30,160,990	UK£469.6m	-7.9%	0.22%
0.72%	Royal London Asset Management Ltd.	29,395,873	UK£457.7m	47.2%	0.72%
0.7%	Amundi Asset Management SAS	28,555,149	UK£444.6m	7.03%	0.12%
0.67%	Causeway Capital Management LLC	27,277,677	UK£424.7m	-9.39%	2.27%
0.65%	Northern Trust Global Investments	26,587,941	UK£414.0m	7.05%	0.08%